The life sciences are largely driven by innovation and growth. What lies beneath those two drivers is a world of complexity across the drug or device life cycle. It’s clear that those companies that can continuously and collaboratively ensure quality, meet regulatory compliance, and mitigate risks in each stage of the life cycle have a competitive advantage, but what’s needed to do so?

LNS Research’s recent survey reveals some interesting data on this topic. We asked two separate questions specifically to life sciences executives and senior leaders regarding the top trends affecting their operations, as well as the top challenges in seamlessly getting products from R&D to the patient or customer.

Looking at the data from this survey, it is clear that there needs to be a tighter integration between quality management and manufacturing. In this article, we’ll provide some context around the need for that integration.

 …